Visual registration, in which multiparametric MRI targets are translated onto real-time ultrasound images, combined with image fusion software may offer the highest detection rate of clinically significantly prostate cancer and thus could aid in risk stratification, according to a new study published in European Urology. Dr. Catalona commented to Renal & Urology News, “Cost is a big issue in the US, where MRI scans are far more expensive, and many insurance companies do not cover them unless the patient has had a prior negative biopsy but still has a rising PSA.”

Subscribe to Quest

"*" indicates required fields

Email

This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*
Address*